Partner
Michael Liang
Managing Partner, InVivium Capital
- Firm
- InVivium Capital
- Title
- Managing Partner
- Role
- Managing partner
- Known as
- Investor
Record updated 21 September 2026
About
Michael Liang, Ph.D. has been a venture capital investor for the past 25 years and is currently a Founder and Managing Partner of InVivium Capital, focusing on investments across life sciences. Previously, Mike spent 16 years as a Partner with Baird Capital, overseeing healthcare venture investments. Prior to joining Baird Capital, Mike was a healthcare investor with Advent Venture Partners (London, U.K.) and before that served in an operating role as a Director of R&D at Cortek, a spinal orthopedics company. Mike currently serves on the Board of Directors of Onchilles Pharma and Infinant Health and was also previously a Board Member of Alto Neuroscience (NYSE: ANRO), GreenLight Biosciences (NASDAQ: GRNA), Interlace Medical (sold to Hologic), OncoHealth (sold to Arsenal Capital Partners), Veniti (sold to Boston Scientific), and a board observer of TomoTherapy (NASDAQ: TOMO, sold to Accuray). Mike received a B.S. in bioorganic chemistry from the University of California, Berkeley, compl
Is this you? Remove my profile